Journal
NANO TODAY
Volume 41, Issue -, Pages -Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.nantod.2021.101308
Keywords
COVID-19; SARS-CoV-2; DNA nanotechnology; Fuel dissipation; Kinetic simulation; MD simulation; Toehold mediated strand displacement; Exonuclease III
Categories
Funding
- State Key Research Development Program of China [2019YFC1200500, 2019YFC1200502]
- National Natural Science Foundation of China [31971361]
- Natural Science Foundation of Beijing Municipality [5212013]
- Fundamental Research Funds for the Central Universities
- National Mega-project for Innovative Drugs [2019ZX09721001-007-002]
- Research projects on biomedical transformation of China-Japan Friendship Hospital [XK-2020-08]
Ask authors/readers for more resources
The COVID-19 pandemic has had a significant impact on human health and the global economy. A self-resetting molecular probe has been developed using DNA nanotechnology to detect SARS-CoV-2 RNA repeatedly, with consistent signal amplitudes and fingerprint signals suitable for high confidential identifications of single-nucleotide variants. The probe also shows the ability to detect multiple human-infectious RNA viruses, enhancing screening capabilities for COVID-19 and other infectious diseases.
A once-in-a-century global public health crisis, the COVID-19 pandemic has damaged human health and world economy greatly. To help combat the virus, we report a self-resetting molecular probe capable of repeatedly detecting SARS-CoV-2 RNA, developed by orchestrating a fuel dissipative system via DNA nanotechnology. A set of simulation toolkits was utilized to design the probe, permitting highly consistent signal amplitudes across cyclic detections. Uniquely, full width at half maximum regulated by dissipative kinetics exhibits a fingerprint signal suitable for high confidential identifications of single-nucleotide variants. Further examination on multiple human-infectious RNA viruses, including ZIKV, MERS-CoV, and SARS-CoV, demonstrates the generic detection capability and superior orthogonality of the probe. It also correctly classified all the clinical samples from 55 COVID-19 patients and 55 controls. Greatly enhancing the screening capability for COVID-19 and other infectious diseases, this probe could help with disease control and build a broader global public health agenda. (c) 2021 Elsevier Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available